ACONW
Aclarion, Inc.Warrants of Aclarion, Inc. · ACON stock page →
—
Market cap
$74.4K
Nano cap
1 year
−74.4%
from $7.55 · Oct 24
30 days
−26.6%
from $2.63
52-week range
$1.85–8.17
−76% from high · low Oct 16
Avg volume 20D
25.7K
Sep 29 spike 79.6K
Short interest
67.5K
≈2.3% of shares · +1.8%
Days to cover
5.6
at average volume
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- E May 5 FDA: Aclarion Announces Second Commercial Agreement with Weill…
- E Jun 1 FDA: Aclarion Technology Demonstrates Potential Beyond Surgical…
- X Jul 15 Short interest falls 42.8% to 2.6K
- X Jul 31 Short interest jumps 5197.7% to 138.9K
- X Aug 14 Short interest jumps 66.9% to 231.8K
- X Aug 31 Short interest falls 69.9% to 69.9K
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q4 2025: 1 added (0 new), 0 trimmed or exited.
- Short sellersSTEADY
Short interest +1.8% to 67.5K shares. 5.6 days to cover, ≈2.3% of shares.
- TrendDOWNTREND
19% below its 50-day average.
Who's buying
13F· Q4 20250
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $100.00 |
| BANK OF AMERICA CORP /DE/ | ADD | $13.00 |
| UBS Group AG | DOUBLED | $34.00 |
| UBS Group AG | DOUBLED | $5.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 21, 2026
Reg SHO list
Reg SHO Threshold: ACONW exited the threshold list
ACLARION INC WT EXP | On list since 2026-08-03
Aug 12, 2026
Press release
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
Aug 3, 2026
Reg SHO list
Reg SHO Threshold: ACONW entered the threshold list
ACLARION INC WT EXP | 5+ consecutive settlement days of fails-to-deliver ≥10k shares and ≥0.5% of shares outstanding
Jul 7, 2026
Press release
Aclarion Announces Texas Spine Care Center as New CLARITY Site
Aclarion Announces Texas Spine Care Center as New CLARITY Site
Jun 10, 2026
Press release
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Earnings setup
EstimatesRevision history: 🔒 Fresh data — subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data — subscribers only | |||
| Next Q | 🔒 Fresh data — subscribers only | |||
| Current FY | 🔒 Fresh data — subscribers only | |||
| Next FY | 🔒 Fresh data — subscribers only | |||
Short side
FINRA· Sep 30, 202667,490
shares short
+1.8%
vs prior settlement
5.6
days to cover
≈2.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 21, 2026 Reg SHO
Apr 22, 2026 SEC Reg SHO Threshold: ACONW exited the threshold list
ACLARION INC WT EXP | On list since 2026-08-03
Aclarion, Inc. announced a $2.5 million share repurchase program authorized by its board, to be executed over the next…
8-K — Impact 4/10
Dec 31, 2025 Inst.
UBS Group AG — DOUBLED
2,643 shares ($100.00)
Sep 30, 2025 Inst.
BANK OF AMERICA CORP — ADD
437 shares ($13.00)
SecBot reports
1 filings · 0 bullish · 0 bearish · 1 neutralAll ACONW filing & press-release reports (1)
- 8-K reportApr 22, 2026